Clinical trial
Efficacy and Safety of ALGRX 3268 in Management of Needlestick Pain in Children.
NCT00140088 · AlgoRx Pharmaceuticals, Industry · Completed
Key facts
| NCT number | NCT00140088 |
|---|---|
| Title | Efficacy and Safety of ALGRX 3268 in Management of Needlestick Pain in Children. |
| Official title | A Phase III, Randomized, Double-Blind, Placebo-Controlled Study to Confirm the Effectiveness and Safety of ALGRX 3268 in Pediatric Subjects. |
| Lead sponsor | AlgoRx Pharmaceuticals, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Procedural Pain |
| Intervention type | Drug |
| Interventions | ALGRX 3268 |
| Enrollment | 504 |
| Start date | Dec 1, 2004 |
| Completion | Apr 1, 2005 |
| First posted | Sep 1, 2005 |
| Last update posted | Sep 1, 2005 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: